BenchSci, a disease biology generative AI platform, announced a three-year agreement with biopharmaceutical company Sanofi to deploy and use its Ascend platform throughout Sanofi's preclinical ...
A drug once dismissed as ineffective suddenly worked—when scientists tested it under more realistic conditions that mimic the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results